Literature DB >> 2376447

Hospital versus neighbourhood controls in the assessment of dietary risk factors.

C A González1, M Torrent, A Agudo, E Riboli.   

Abstract

The selection of the best control group is a major concern in the design of any case-control study, because of its enormous implications on both interval validity and cost. We compare the dietary habits of hospital and neighbourhood control groups which had both been used in a case-control study on bladder cancer. The analysis is based on 485 matched sets. No differences were observed between the two groups in terms of nutrient consumption nor in consumption of specific foods or food groups. Alcohol consumption represents an exception. This may be attributed to the use of incorrect exclusion criteria given that alcohol consumption was not one of the major determinants of the original study. We conclude that, provided correct exclusion criteria are used, hospital controls may be a suitable as neighbourhood controls in the assessment of dietary risk factors in case-control studies in Spain.

Entities:  

Mesh:

Year:  1990        PMID: 2376447     DOI: 10.1093/ije/19.2.354

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  3 in total

1.  Risk factors for the development of colorectal carcinoma: A case control study from South India.

Authors:  Santhana Krishnan Iswarya; Kariyarath Cheriyath Premarajan; Sitanshu Sekhar Kar; Sathasivam Suresh Kumar; Vikram Kate
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

2.  Consumption of alcohol, coffee, and tobacco, and gastric cancer in Spain.

Authors:  A Agudo; C A González; G Marcos; M Sanz; E Saigi; J Verge; M Boleda; J Ortego
Journal:  Cancer Causes Control       Date:  1992-03       Impact factor: 2.506

3.  Colon cancer controls versus population controls in case-control studies of occupational risk factors.

Authors:  Linda Kaerlev; Elsebeth Lynge; Svend Sabroe; Jorn Olsen
Journal:  BMC Cancer       Date:  2004-04-22       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.